We read with interest a meta-analysis published in Angiology titled-"Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials" by Xie et al. 1 We would like to congratulate the authors for their publication. However, we would like to make the following observations.
1) The authors have failed to report the method and model used for pooling the estimates in the statistical analysis section. 2) All the pooled estimates of secondary outcomes are associated with the error of "double counting." For example, the study by Min Liang (2017) has been included twice for pooled estimation of serum creatinine levels in experiment and control groups, once under the subgroup 48 hours and included again under subgroup of 72 hours. 2,3 3) Even with subgroup analysis, the authors have failed to determine the cause of heterogeneity in the pooled estimates of their secondary outcomes. The authors deferred from using meta-regression to assess the cause of this heterogeneity, though the same was mentioned in the methodology.
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